Mollnes TE - Search Results

1

Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Hellerud BC, Stenvik J, Espevik T, Lambris JD, Mollnes TE, Brandtzaeg P. Hellerud BC, et al. Among authors: mollnes te. Infect Immun. 2008 Sep;76(9):4183-9. doi: 10.1128/IAI.00195-08. Epub 2008 Jun 30. Infect Immun. 2008. PMID: 18591229 Free PMC article.

2

Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant.

Bjerre A, Brusletto B, Mollnes TE, Fritzsønn E, Rosenqvist E, Wedege E, Namork E, Kierulf P, Brandtzaeg P. Bjerre A, et al. Among authors: mollnes te. J Infect Dis. 2002 Jan 15;185(2):220-8. doi: 10.1086/338269. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807696

3

Complement in inflammatory tissue damage and disease.

Mollnes TE, Song WC, Lambris JD. Mollnes TE, et al. Trends Immunol. 2002 Feb;23(2):61-4. doi: 10.1016/s1471-4906(01)02129-9. Trends Immunol. 2002. PMID: 11929126 No abstract available.

4

Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, Videm V, Lappegård KT, Köhl J, Lambris JD. Mollnes TE, et al. Blood. 2002 Sep 1;100(5):1869-77. Blood. 2002. PMID: 12176911 Free article.

5

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

Sprong T, Brandtzaeg P, Fung M, Pharo AM, Høiby EA, Michaelsen TE, Aase A, van der Meer JW, van Deuren M, Mollnes TE. Sprong T, et al. Among authors: mollnes te. Blood. 2003 Nov 15;102(10):3702-10. doi: 10.1182/blood-2003-03-0703. Epub 2003 Jul 24. Blood. 2003. PMID: 12881318 Free article.

6

Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.

Lappegård KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE. Lappegård KT, et al. Among authors: mollnes te. Ann Thorac Surg. 2004 Mar;77(3):932-41. doi: 10.1016/S0003-4975(03)01519-4. Ann Thorac Surg. 2004. PMID: 14992902

7

Soluble toll-like receptor 2 in HIV infection: association with disease progression.

Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS. Heggelund L, et al. Among authors: mollnes te. AIDS. 2004 Dec 3;18(18):2437-9. AIDS. 2004. PMID: 15622324 Clinical Trial. No abstract available.

8

Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production.

Lappegård KT, Riesenfeld J, Brekke OL, Bergseth G, Lambris JD, Mollnes TE. Lappegård KT, et al. Among authors: mollnes te. Ann Thorac Surg. 2005 Mar;79(3):917-23. doi: 10.1016/j.athoracsur.2004.08.015. Ann Thorac Surg. 2005. PMID: 15734405

9

The role of complement in biomaterial-induced inflammation.

Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Nilsson B, et al. Among authors: mollnes te. Mol Immunol. 2007 Jan;44(1-3):82-94. doi: 10.1016/j.molimm.2006.06.020. Epub 2006 Aug 14. Mol Immunol. 2007. PMID: 16905192 Review.

10

Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction.

Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P. Ueland T, et al. Among authors: mollnes te. J Card Fail. 2006 Oct;12(8):659-63. doi: 10.1016/j.cardfail.2006.07.002. J Card Fail. 2006. PMID: 17045187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters